OTC · Financial Statements

Bloomios, Inc. (BLMS) Financial Statements

$0.00 OTC: BLMS Market Cap $19341

Bloomios, Inc. most recently reported annual revenue of $6.0M, net profit of $-14.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20182019202020212022
Revenue$0$0$1.0M$8.0M$6.0M
Operating Profit$0$0$-1.0M$-1.0M$-4.0M
Net Profit$0$0$-1.0M$-2.0M$-14.0M
EPS$0.00$0.00$-0.09$-0.16$-1.04
Op Margin——-80.8%-9.4%-68.1%

Balance Sheet (USD)

Metric20182019202020212022
Total Assets—$0$3.0M$4.0M$26.0M
Total Liabilities—$0$4.0M$6.0M$27.0M
Cash—$0$0$0$0
Borrowings$0$0$2.0M$3.0M$22.0M

Cash Flow (USD)

Metric20182019202020212022
Operating Cash Flow$0$0$1.0M$0$-6.0M
Investing Cash Flow$0$0$-5.0M$-2.0M$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$0$0$-1.0M$-1.0M$-6.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-2.83
FCF Yield-32831.48%
Quick Ratio0.02
Interest Coverage-0.50
Return 1Y200.00%
Return 3Y-98.32%
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
BLMS Overview BLMS Dividend Run Stock Screener